Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

Abstract Levodopa is the standard long-term dopamine replacement therapy to treat Parkinson’s disease (PD) symptoms. With time, levodopa may induce debilitating dyskinesias (LID), the treatment of which represents a large clinically unmet need. However, time-to-LID onset varies between patients, ref...

Full description

Saved in:
Bibliographic Details
Main Authors: Eva König, Alessandra Nicoletti, Cristian Pattaro, Grazia Annesi, Roberto Melotti, Alessandro Gialluisi, Christine Schwienbacher, Anne Picard, Hagen Blankenburg, Irene Pichler, Nicola Modugno, Marina Ciullo, Teresa Esposito, Francisco S. Domingues, Andrew A. Hicks, Mario Zappia, Peter P. Pramstaller
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/729fb5b9e7544bd191b10488b78de1e8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/729fb5b9e7544bd191b10488b78de1e8

Similar Items